IP Library Granted Patent US 9,588,076
Granted Patent B2
US 9,588,076 · App. 14/426,642 · Granted Mar 7, 2017

Biosensor and method for manufacturing biosensor

Inventors: Setuko Yano (Ehime, JP); Kazumasa Miyamoto (Ehime, JP); Shinki Kojima (Ehime, JP); Tomoharu Yamamura (Ehime, JP); Kanako Matsushima (Ehime, JP)
Assignee: Panasonic Healthcare Holdings Co., Ltd.
G01N27/3271C12Q1/006G01N27/3272
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,588,076
App. No.
14/426,642
Granted
Mar 7, 2017
Kind
B2
Abstract

The present invention relates to a biosensor, and it is an object thereof to suppress degradation by light. A biosensor ( 2 ) comprises a blood component measurement working electrode ( 5 ), a blood component measurement counter electrode ( 6 ), and a reagent component ( 9 ). The reagent component ( 9 ) is provided near the blood component measurement working electrode ( 5 ) and the blood component measurement counter electrode ( 6 ). The reagent component ( 9 ) includes a mediator, an oxidoreductase, and a substance that absorbs light with a wavelength of 400 to 500 nm. An insulated substrate ( 4 ) is provided, on the surface of which is disposed the blood component measurement working electrode ( 5 ) and/or the blood component measurement counter electrode ( 6 ). The reagent component ( 9 ) is disposed on the one or more electrodes on the insulated substrate ( 4 ).

Claims (52)

1. A biosensor, comprising:

a first electrode;

a second electrode; and

a reagent component that is provided near the first electrode and the second electrode,

wherein the reagent component includes:

a mediator;

an oxidoreductase; and

Fast Green FCF that absorbs light with a wavelength of 400 to 500 nm, and

the Fast Green FCF is present in the reagent component in a weight ratio of at least 6.01% and no more than 39.02%.

2. The biosensor according to claim 1 , comprising:

a substrate, the first electrode and/or the second electrode being disposed on a surface thereof,

wherein the reagent component is disposed on one or both of the first electrode and the second electrode on the substrate.

3. The biosensor according to claim 2 ,

wherein the reagent component is formed such that an outer peripheral portion is thicker than an inner portion on the substrate.

4. The biosensor according to claim 3 ,

wherein the reagent component has a circular shape in plan view on the substrate.

5. The biosensor according to claim 2 , comprising:

a spacer laminated on a side of the substrate where the reagent component is formed; and

a transparent or semitransparent cover laminated on an opposite side of the spacer from the substrate,

wherein a biological sample introduction component that guides a biological sample to a portion corresponding to the reagent component is formed in the spacer.

6. The biosensor according to claim 1 ,

wherein the Fast Green FCF that absorbs light with a wavelength of 400 to 500 nm is disposed with a hydrophobic benzene ring portion facing a surface layer side of the reagent component.

7. The biosensor according to claim 1 ,

wherein the number of moles of the Fast Green FCF that absorbs light with a wavelength of 400 to 500 nm is less than the number of moles of the mediator.

8. The biosensor according to claim 1 ,

wherein the ratio of the number of moles of Fast Green FCF to the number of moles of the mediator is at least 0.0442 and no more than 0.422.

9. A biosensor, comprising:

a first electrode;

a second electrode; and

a reagent component that is provided near the first electrode and the second electrode,

wherein the reagent component includes:

a mediator;

an oxidoreductase; and

Brilliant Blue FCF that absorbs light with a wavelength of 400 to 500 nm, and

the Brilliant Blue FCF is present in the reagent component in a weight ratio of at least 5.9% and no more than 23.87%.

10. The biosensor according to claim 9 ,

wherein the ratio of the number of moles of the Brilliant Blue FCF to the number of moles of the mediator is at least 0.0442 and no more than 0.221.

11. The biosensor according to claim 9 , comprising:

a substrate, the first electrode, and/or the second electrode being disposed on a surface thereof,

wherein the reagent component is disposed on one or both of the first electrode and the second electrode on the substrate.

12. The biosensor according to claim 11 ,

wherein the reagent component is formed such that an outer peripheral portion is thicker than an inner portion on the substrate.

13. The biosensor according to claim 12 ,

wherein the reagent component has a circular shape in plan view on the substrate.

14. The biosensor according to claim 11 comprising:

a spacer laminated on a side of the substrate where the reagent component is formed; and

a transparent or semitransparent cover laminated on an opposite side of the spacer from the substrate,

wherein a biological sample introduction component that guides a biological sample to a portion corresponding to the reagent component is formed in the spacer.

15. The biosensor according to claim 9 ,

wherein the Brilliant Blue FCF that absorbs light with a wavelength of 400 to 500 nm is disposed with a hydrophobic benzene ring portion facing a surface layer side of the reagent component.

16. The biosensor according to claim 9 ,

wherein the number of moles of the Brilliant Blue FCF that absorbs light with a wavelength of 400 to 500 nm is less than the number of moles of the mediator.

Assignments (2)
CHANGE OF NAME Recorded Jun 29, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046459/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2015
From: YANO, SETUKO; MIYAMOTO, KAZUMASA; KOJIMA, SHINKI; YAMAMURA, TOMOHARU; MATSUSHIMA, KANAKO
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 035106/0587 →
Priority Claims (1)
JP 2012-205274 · Sep 19, 2012 · national
Continuity (1)
Related Publication 20150241377A1 · Aug 27, 2015